<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02862834</url>
  </required_header>
  <id_info>
    <org_study_id>Courcet AOI 2012</org_study_id>
    <nct_id>NCT02862834</nct_id>
  </id_info>
  <brief_title>Screening for Genes in Patients With Poikiloderma</brief_title>
  <acronym>poikiloderma</acronym>
  <official_title>Towards an Improvement in Diagnosis and Genetic Counselling in Syndromic Poikiloderma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      In the context of this study, the investigators wish to take advantage of high-throughput
      genetic techniques (microarray and high-throughput exome sequencing) to identify new genes
      implicated in syndromic poikiloderma so as to improve the diagnostic decision tree in these
      syndromes, opportunities for genetic counselling for patients and their families and the
      follow-up of patients, notably with regard to the risk of tumours.

      This study will make it possible to identify new genes implicated in syndromic poikiloderma
      and improve the diagnostic strategy proposed to patients with these syndromes, and to propose
      to patients a confirmed diagnosis, appropriate follow-up, notably with regard to the risk of
      tumours, genetic counselling to families and eventually an antenatal diagnosis to couples who
      would like to have one for future pregnancies.

      The identification of new genetic causes of syndromic poikiloderma will also make it possible
      to complete the current classification of these syndromes
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of novel genes involved in syndromic poikiloderma</measure>
    <time_frame>day 1</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">39</enrollment>
  <condition>Poikiloderma</condition>
  <arm_group>
    <arm_group_label>patients with poikiloderma</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>High-throughput exome sequencing</intervention_name>
    <arm_group_label>patients with poikiloderma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with poikiloderma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        patients with syndromic poikiloderma, defined by the association of poikiloderma with other
        extradermatological clinical signs,

          -  normal array-CGH, screening for chromosomal rearrangements,

          -  absence of mutations in the genes RECQL4, KIND1 or C16orf57,

          -  sporadic or familial involvement.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2016</study_first_submitted>
  <study_first_submitted_qc>August 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>August 10, 2016</last_update_submitted>
  <last_update_submitted_qc>August 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

